CymaBay Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

CymaBay Therapeutics, Inc. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include CYMABAY, LIVDELZI, and CYMABAY THERAPEUTICS. The owner is based in Newark, CA.

7575 Gateway Blvd., Suite 110

Newark, CA 94560

22 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CymaBay Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does CymaBay Therapeutics, Inc. have?

CymaBay Therapeutics, Inc. has 22 U.S. trademarks filed with the USPTO. Of these, 8 registered, 14 abandoned.

What trademark classes does CymaBay Therapeutics, Inc. file in?

CymaBay Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CymaBay Therapeutics, Inc.'s most well-known trademarks?

CymaBay Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CYMABAY, LIVDELZI, and CYMABAY THERAPEUTICS. These are among 8 currently registered trademarks in the portfolio.

What is CymaBay Therapeutics, Inc.'s trademark registration success rate?

CymaBay Therapeutics, Inc. has a 36% trademark registration rate, with 8 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.